Psychotherapy + Survey Administration + Psilocybin for anxiety disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Jan 2026: Trial registered, NCT07336238
  2. 19 May 2026: Trial started, NCT07336238

The trials

NCT07336238: Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

State
Under way
Phase
Phase 2
People
16 taking part
Started
19 May 2026
Primary completion
1 Dec 2026
Arms
Treatment (psilocybin therapy)
Results
None posted
  1. 13 Jan 2026: Trial registered
  2. 19 May 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.